For interviews with the report authors, please contact Dr Waasila Jassat, National Institute for Communicable Diseases of the National Health Laboratory Service, South Africa E) waasilaj@nicd.ac.za T) +27(0)82 927 4138
Alternative contact in the ECCMID Press Room: Tony Kirby T) + 44(0)7834 385827 E) tony@tonykirby.com or Rachael Davies T) +44(0)797 456 0784 E) rachaelvdavies@hotmail.co.uk
Notes to editors:
[1] Wave 1: (14721 deaths/59617625 SA population)*100,000 = 24.7 deaths per 100,000 people Wave 2: (28682 deaths/59617625 SA population)*100,000 = 48.1 deaths per 100,000 people
[2] Coronavirus deaths by country in Africa 2021 | Statista / South Africa | UNAIDS https://www.statista.com/statistics/1170530/coronavirus-deaths-in-africa/
[3] See table 1; weeks with very high admissions; 27,949 deaths among 104,058 patients with outcomes (case fatality risk 26.9%). Weeks with low admissions; 8,985 deaths among 50,840 patients with outcomes (case fatality risk 17.7%).
The surveillance was funded by the National Institute for Communicable Diseases and the South African Government. The study did not receive any additional funding.
The authors declare no conflicts of interest.
The Lancet Global Health: Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study
Article available under embargo at (journalist only link): http://www.thelancet-press.com/embargo/tlgh.pdf
Appendix available under embargo at (journalist only link): http://www.thelancet-press.com/embargo/tlghAPPX.pdf
NOTE: THE ABOVE LINK IS FOR JOURNALISTS ONLY AND WILL BE DEACTIVATED AFTER THE EMBARGO LIFTS. IF YOU WISH TO PROVIDE A LINK TO THIS PAPER FOR YOUR READERS, PLEASE USE THE FOLLOWING, WHICH WILL GO LIVE WHEN THE EMBARGO LIFTS:
http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00289-8/fulltext
Journal
The Lancet Global Health